<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Frequent idiopathic premature ventricular complexes (<z:mp ids='MP_0010018'>PVCs</z:mp>) can result in a reversible form of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, the determinants of <z:mp ids='MP_0010018'>PVC</z:mp>-induced left ventricular (LV) dysfunction were assessed </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The subjects of this study were 241 consecutive patients (115 men [48%], mean age 48 ± 14 years) referred for ablation of frequent <z:mp ids='MP_0010018'>PVCs</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>One hundred eighty patients (75%) experienced <z:hpo ids='HP_0001962'>palpitations</z:hpo> and 61 (25%) did not </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:mp ids='MP_0010018'>PVC</z:mp> burden was determined by 24-hour Holter monitoring, and echocardiograms were performed to assess LV function </plain></SENT>
<SENT sid="5" pm="."><plain>An LV ejection fraction of &lt;50% was considered abnormal </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: LV ejection fraction (mean 0.36 ± 0.09) was present in 76 of 241 patients (32%) </plain></SENT>
<SENT sid="7" pm="."><plain>There was a higher prevalence of males among the patients with <z:mp ids='MP_0010018'>PVC</z:mp> <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> compared to patients with <z:mpath ids='MPATH_458'>normal</z:mpath> LV function (51/76 [67%] vs 64/165 [39%]; P &lt;.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>The mean <z:mp ids='MP_0010018'>PVC</z:mp> burden was significantly higher in patients with <z:mp ids='MP_0010018'>PVC</z:mp> <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> than in patients with <z:mpath ids='MPATH_458'>normal</z:mpath> LV function (28% ± 12% vs 15% ± 13%; P &lt;.0001) </plain></SENT>
<SENT sid="9" pm="."><plain>Among symptomatic patients, those with <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> had a significantly longer duration of <z:hpo ids='HP_0001962'>palpitations</z:hpo> (135 ± 118 months) compared with patients with <z:mpath ids='MPATH_458'>normal</z:mpath> LV function (35 ± 52 months; P &lt;.0001) </plain></SENT>
<SENT sid="10" pm="."><plain>The proportion of asymptomatic patients was significantly higher in the presence of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (36/76, 47%) than in <z:mpath ids='MPATH_458'>normal</z:mpath> LV function (25/165, 15%; P &lt;.0001) </plain></SENT>
<SENT sid="11" pm="."><plain>Symptom duration of 30 to 60 months, symptom duration &gt;60 months, the absence of symptoms, and the <z:mp ids='MP_0010018'>PVC</z:mp> burden in asymptomatic patients were independent predictors of impaired LV function (adjusted odds ratio [95% confidence interval]: 4.0 [1.1-14.4], 20.1 [6.3-64.1], 13.1 [4.1-37.8], and 2.1 [1.2-3.6], respectively) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: The duration of <z:hpo ids='HP_0001962'>palpitations</z:hpo> and the absence of symptoms are independently associated with <z:mp ids='MP_0010018'>PVC</z:mp>-induced <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>